Home > Tools & Resources > FLUAD® Real-World Evidence (RWE) Studies

FLUAD® Real-World Evidence (RWE) Studies

Consider both clinical trial and RWE data when choosing an influenza vaccine. Explore RWE studies across multiple influenza seasons to learn more about the clinical effectiveness of FLUAD (Influenza Vaccine, Adjuvanted).

Download
Flyer that highlights FLUAD and its clinical effectiveness for adults 65+ years.

Resource Notes:

Attributes Checklist
  • Presents 20+ years of RWE studies
  • Details findings by end points, study results, seasons, study design, and key limitations
  • Includes FLUAD® (Influenza Vaccine, Adjuvanted) vs standard-dose and high-dose influenza vaccines

Additional Resources

Flyer that highlights FLUCELVAX and its clinical effectiveness for patients 6+ months.

FLUCELVAX | CLINICAL

FLUCELVAX® Real-World Evidence (RWE) Studies

See the RWE of FLUCELVAX (Influenza Vaccine) over multiple seasons for a more complete picture of how it may impact influenza-related clinical outcomes.

Informative flyer that details why FLUAD (Influenza Vaccine, Adjuvanted), an MF59® adjuvanted flu vaccine, is an appropriate option for patients 65+.

FLUAD | CLINICAL

FLUAD® Informational Flyer

Informative flyer that details why FLUAD (Influenza Vaccine, Adjuvanted), an MF59® adjuvanted flu vaccine, is an appropriate option for patients 65+.

Quick reference guide for coding and billing information specific to FLUAD (Influenza Vaccine, Adjuvanted).

FLUAD | FINANCIAL

FLUAD® Coding and Billing Guide

Quick reference guide for coding and billing information specific to FLUAD (Influenza Vaccine, Adjuvanted).